Beijing Tsinghua Chang Gung Hospital
Clinical trials sponsored by Beijing Tsinghua Chang Gung Hospital, explained in plain language.
-
Liver cancer patients get a second chance with combo therapy
Disease control CompletedThis study looked at 24 adults with advanced liver cancer whose tumors continued to grow despite standard treatment with lenvatinib and a PD-1 inhibitor. Researchers added lenalidomide to see if it could help control the cancer again. The goal was to measure how long patients liv…
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Surgeons propose new way to classify bile duct disease for better operations
Knowledge-focused CompletedThis study looked at 234 adults who had surgery for a rare bile duct condition called congenital biliary dilation. Researchers created a new classification system to help surgeons decide the best operation for each patient. The goal was to improve long-term outcomes and reduce co…
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 07:08 UTC
-
Should you operate on a silent bile duct? large study aims to find out
Knowledge-focused CompletedThis study followed over 1,000 people whose bile ducts were found to be wider than normal by chance, even though they had no symptoms. Researchers collected data from 25 hospitals in China to learn how common this condition is, what types exist, and whether surgery helps prevent …
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 06:52 UTC
-
New RNA test reveals which chemo combo hits harder in rare abdominal cancer
Knowledge-focused CompletedThis study tested two different heated chemotherapy regimens (cisplatin alone vs. cisplatin plus docetaxel) in 36 people with pseudomyxoma peritonei, a rare abdominal tumor. Researchers used a new technique called Flura-seq to track changes in tumor RNA right after treatment. The…
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Knowledge-focused
Last updated May 05, 2026 11:54 UTC